Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE)

被引:20
作者
Nekkanti, Vijaykumar [1 ]
Marwah, Ashwani [2 ]
Pillai, Raviraj [2 ]
机构
[1] Western Univ Hlth Sci, Dept Pharm, Pomona, CA USA
[2] Dr Reddys Labs Ltd, Integrated Prod Dev, Hyderabad, Andhra Pradesh, India
关键词
Bead milling; central composite design; design of experiments; process optimization; QbD; FORMULATION; NANOSUSPENSION; MICROPARTICLES; VARIABLES; QUALITY;
D O I
10.3109/03639045.2013.850709
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Design of experiments (DOE), a component of Quality by Design (QbD), is systematic and simultaneous evaluation of process variables to develop a product with predetermined quality attributes. This article presents a case study to understand the effects of process variables in a bead milling process used for manufacture of drug nanoparticles. Experiments were designed and results were computed according to a 3- factor, 3-level face-centered central composite design (CCD). The factors investigated were motor speed, pump speed and bead volume. Responses analyzed for evaluating these effects and interactions were milling time, particle size and process yield. Process validation batches were executed using the optimum process conditions obtained from software Design-Expert (R) to evaluate both the repeatability and reproducibility of bead milling technique. Milling time was optimized to <5 h to obtain the desired particle size (d90<400 nm). The desirability function used to optimize the response variables and observed responses were in agreement with experimental values. These results demonstrated the reliability of selected model for manufacture of drug nanoparticles with predictable quality attributes. The optimization of bead milling process variables by applying DOE resulted in considerable decrease in milling time to achieve the desired particle size. The study indicates the applicability of DOE approach to optimize critical process parameters in the manufacture of drug nanoparticles.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 14 条
  • [1] Development of spray-dried acetaminophen microparticles using experimental designs
    Billon, A
    Bataille, B
    Cassanas, G
    Jacob, M
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 203 (1-2) : 159 - 168
  • [2] Box G.E.P., 1978, STAT EXPT INTRO DESI, P313
  • [3] DERRINGER GC, 1994, QUAL PROG, V27, P51
  • [4] Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation
    Devay, Attila
    Mayer, Klara
    Pal, Szilard
    Antal, Istvan
    [J]. JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2006, 69 (1-2): : 197 - 205
  • [5] Fisher RA, 1935, DESIGN EXPT, P35
  • [6] Liberman H, 1989, PHARM DOSAGE FORMS D, P438
  • [7] Nanosizing: a formulation approach for poorly-water-soluble compounds
    Merisko-Liversidge, E
    Liversidge, GG
    Cooper, ER
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 18 (02) : 113 - 120
  • [8] Nekkanti V, 2008, PHAR TECH EUR, V11, P24
  • [9] Spray-drying process optimization for manufacture of drug-cyclodextrin complex powder using design of experiments
    Nekkanti, Vijaykumar
    Muniyappan, Thilekkumar
    Karatgi, Pradeep
    Hari, Molleti Sri
    Marella, Seshasai
    Pillai, Raviraj
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (10) : 1219 - 1229
  • [10] Optimization of formulation and process variable of nanosuspension: An industrial perspective
    Singare, Dhananjay S.
    Marella, Seshasai
    Gowthamrajan, K.
    Kulkarni, Giriraj T.
    Vooturi, Rajesh
    Rao, Parchuri Srinivasa
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 402 (1-2) : 213 - 220